Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug‐Induced Parkinsonism
José Luis López-Sendón(Hospital Universitario Ramón y Cajal), Juan Carlos Martínez‐Castrillo(Hospital Universitario Ramón y Cajal), J. Buisán Catevilla(Instituto Cajal), Íñigo Corral(Hospital Universitario Ramón y Cajal), Araceli Alonso‐Cánovas(Universidad de Alcalá), María Consuelo Matute Lozano(Hospital Universitario Ramón y Cajal), Jaime Masjuán(Universidad de Alcalá), Nuria García Barragán(Instituto Ramón y Cajal de Investigación Sanitaria), Alicia de Felipe Mimbrera(Universidad de Alcalá)
Cited by 10
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
|The Lancet|2012|280
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
|Journal of Clinical Investigation|2005|257